✨
AI Summary
- Dr. Jak Knowles discusses targeting oncogenic drivers in solid tumors.
- Affini-T Therapeutics engineers immune cells to target mutations like KRAS.
- Minimizing tumor escape mechanisms with novel cellular immunotherapies.
Guests on This Episode
JK
Jak Knowles
1 podcast appearance